UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032889
Receipt number R000037502
Scientific Title Study of the clinical outcome of Goreisan in patients with abnormal fluid retention.
Date of disclosure of the study information 2018/06/06
Last modified on 2018/10/10 13:28:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the clinical outcome of Goreisan in patients with abnormal fluid retention.

Acronym

Study of the clinical outcome of Goreisan in patients with abnormal fluid retention.

Scientific Title

Study of the clinical outcome of Goreisan in patients with abnormal fluid retention.

Scientific Title:Acronym

Study of the clinical outcome of Goreisan in patients with abnormal fluid retention.

Region

Japan


Condition

Condition

Abnormal fluid retention

Classification by specialty

Medicine in general Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the efficacy of Goreisan in patients with abnormal fluid retention.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

A total of 3days urine volume form the day after participation in this study.

Key secondary outcomes

Serum creatinine, electrolyte, liver enzyme, body weight, and the degree of peripheral edema.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Additional administration of Goreisan 7.5g/day on intravenous injection of diuretics for abnormal fluid retention.

Interventions/Control_2

Intravenous injection of diuretics for abnormal fluid retention.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients who need intravenous injection of diuretics due to abnormal fluid retention.
2) Patients who gave written informed consent

Key exclusion criteria

1) Patients younger than 20 years old
2) Patients who have allergy for cinnamon
3) Patients who are pregnant or hope to be pregnant
4) Patients who cannot take oral administration
5) Patients who have no urination due to end-stage renal failure on hemodialysis
6) Patients who are not expected to react to diuretics due to acute kidney injury
7) Patients who participate in another interventional trial
8) Patients whose doctor in charge do not agree to join the trial

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masami Sakurada

Organization

Tokorozawa Heart Center

Division name

Department of Cardiology

Zip code


Address

2-61-11 Kamiarai, Tokorozawa, Saitama, JAPAN 359-1142

TEL

04-2940-8611

Email

hirotakaezaki@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Hirotaka Ezaki

Organization

Tokorozawa Heart Center

Division name

Department of Cardiology

Zip code


Address

2-61-11 Kamiarai, Tokorozawa, Saitama, JAPAN 359-1142

TEL

04-2940-8611

Homepage URL


Email

hirotakaezaki@gmail.com


Sponsor or person

Institute

Tokorozawa Heart Center

Institute

Department

Personal name



Funding Source

Organization

Tokorozawa Heart Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

所沢ハートセンター(埼玉県)


Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 04 Month 20 Day

Date of IRB


Anticipated trial start date

2018 Year 06 Month 06 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 06 Month 06 Day

Last modified on

2018 Year 10 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037502